Lipin deficiency impairs diurnal metabolic fuel switching

J Xu, WNP Lee, J Phan, MF Saad, K Reue… - Diabetes, 2006 - Am Diabetes Assoc
J Xu, WNP Lee, J Phan, MF Saad, K Reue, IJ Kurland
Diabetes, 2006Am Diabetes Assoc
Fatty liver is a common feature of both obesity and lipodystrophy, reflecting compromised
adipose tissue function. The lipin-deficient fatty liver dystrophy (fld) mouse is an exception,
as there is lipodystrophy without a fatty liver. Using a combination of indirect calorimetry and
stable-isotope flux phenotyping, we determined that fld mice exhibit abnormal fuel utilization
throughout the diurnal cycle, with increased glucose oxidation near the end of the fasting
period and increased fatty acid oxidation during the feeding period. The mechanisms …
Fatty liver is a common feature of both obesity and lipodystrophy, reflecting compromised adipose tissue function. The lipin-deficient fatty liver dystrophy (fld) mouse is an exception, as there is lipodystrophy without a fatty liver. Using a combination of indirect calorimetry and stable-isotope flux phenotyping, we determined that fld mice exhibit abnormal fuel utilization throughout the diurnal cycle, with increased glucose oxidation near the end of the fasting period and increased fatty acid oxidation during the feeding period. The mechanisms underlying these alterations include a twofold increase compared with wild-type mice in tissue glycogen storage during the fed state, a 40% reduction in hepatic glucose production in the fasted state, and a 27-fold increase in de novo fatty acid synthesis in liver during the fed state. Thus, the inability to store energy in adipose tissue in the fld mouse leads to a compensatory increase in glycogen storage for use during the fasting period and reliance upon hepatic fatty acid synthesis to provide fuel for peripheral tissues during the fed state. The increase in hepatic fatty acid synthesis and peripheral utilization provides a potential mechanism to ameliorate fatty liver in the fld that would otherwise occur as a consequence of adipose tissue dysfunction.
Am Diabetes Assoc